Establishing a Graft-Versus-Host Disease (GVHD)-Focused Multidisciplinary Telehealth Clinic

被引:0
|
作者
Harris, Andrew C. [1 ]
Markova, Alina [2 ]
Devlin, Sean [3 ]
Singh, Amandeep [4 ]
Susman, Pamela [4 ]
Brown, Soni [4 ]
Grasso, Christine [4 ]
Custodio, Christian [5 ]
Estilo, Cherry [6 ]
Ibanez, Katarzyna [5 ]
Myers, Michelle [7 ]
Syrkin, Grigory [5 ]
Yom, Saehee [6 ]
Perales, Miguel-Angel [4 ,8 ]
Ponce, Doris M. [4 ,8 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Bone Marrow Transplant Serv, Dept Pediat, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, Dept Dermatol, New York, NY USA
[3] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY USA
[4] Mem Sloan Kettering Canc Ctr, Dept Med, Adult Bone Marrow Transplant Serv, New York, NY USA
[5] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY USA
[6] Mem Sloan Kettering Canc Ctr, Dept Surg, Dent Serv, New York, NY USA
[7] Mem Sloan Kettering Canc Ctr, Dept Food & Nutr, New York, NY USA
[8] Weill Cornell Med Coll, New York, NY USA
来源
TRANSPLANTATION AND CELLULAR THERAPY | 2024年 / 30卷 / 12期
关键词
GVHD; Telehealth; CONSENSUS DEVELOPMENT PROJECT; STEM-CELL TRANSPLANTATION; CRITERIA; TRIALS; DIAGNOSIS; OUTCOMES; BLOOD; RACE;
D O I
10.1016/j.jtct.2024.09.016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Graft-versus-host disease (GVHD) is a complication following allogeneic hematopoietic cell transplant that frequently causes multiorgan affection and decrease in quality of life. Global assessment and care of these patients require a multidisciplinary approach, but access to focused clinics is limited given their scarcity and location in major cities, as well as mobility and transportation challenges that frequently affect these patients. Thus, we established a multispecialty GVHD telehealth (TH) clinic and hypothesized that a virtual platform will expand access to clinical care in children and adults. The clinic team members included BMT specialist, nursing, dermatologist, dentist, nutritionist, physiatrist, research personnel, and others as needed. We evaluated all GVHD-related visits (in-person and TH) conducted in a single center from 01/2022 to 12/2022. Ninety-three patients received a total of 308 visits, and one-third were via TH. Approximately half of the in-person group had at least 1 TH visit, and 10 patients were seen exclusively via TH. Most patients had advanced chronic GVHD. More male patients were seen in GVHD clinic, but female patients had increased in clinic visits via TH (41% TH versus 32% in-person). One-third of clinic visits were from patients of racial and ethnic minorities. While only 6% (n = 12/217) of in-person visits were for patients living >100 miles from the center, 34% (n = 31/91) of TH visits were from far distances including out-of-state. At baseline, the most common patient-reported symptoms in a subset of patients included fatigue, disturbed sleep, and distress. Fifteen patients completed a follow-up symptom survey and reported significantly reduced distress regarding their GVHD (P = .02), although other symptoms remained stable. A multidisciplinary TH clinic provided care for adult and pediatric patients with GVHD. We demonstrated preliminary feasibility of building a robust TH platform with a collaborative multispecialty approach that allowed access and continuity of medical care. Gender inequalities were reduced, and distance to our center represented a lesser barrier to attending specialized care via TH. Additionally, patients reported a significant reduction in distress. Our findings support the ongoing development of a virtual platform to improve access to specialized GVHD care.
引用
收藏
页码:1215e1 / 1215e11
页数:11
相关论文
共 50 条
  • [1] GRAFT-VERSUS-HOST DISEASE (GVHD)
    VOLCPLATZER, B
    HAUTARZT, 1992, 43 (10): : 669 - 677
  • [2] GENETIC INFLUENCES ON GRAFT-VERSUS-HOST DISEASE (GVHD)
    ALLEN, RD
    FASEB JOURNAL, 1995, 9 (03): : A501 - A501
  • [3] Rosiglitazone prevents graft-versus-host disease (GVHD)
    Song, Eun-Kee
    Yim, Jun-Mo
    Yim, Joo-Yun
    Song, Min-Young
    Rho, Hye-Won
    Yim, Sung Kyun
    Jeon, So Yeon
    Kim, Hee Sun
    Yhim, Ho-Young
    Lee, Na-Ri
    Kwak, Jae-Yong
    Sohn, Myung-Hee
    Park, Ho Sung
    Jang, Kyu Yun
    Yim, Chang-Yeol
    TRANSPLANT IMMUNOLOGY, 2012, 27 (2-3) : 128 - 137
  • [4] Chronic Graft-Versus-Host Disease (GVHD) in Children
    Baird, Kristin
    Cooke, Kenneth
    Schultz, Kirk R.
    PEDIATRIC CLINICS OF NORTH AMERICA, 2010, 57 (01) : 297 - +
  • [5] Rosiglitazone prevents graft-versus-host disease (GVHD)
    Song, Eun-Kee
    Yhim, Ho-Young
    Yim, Jun-Mo
    Yim, Joo-Yun
    Song, Min-Young
    Lee, Na-Ri
    Kwak, Jae-Yong
    Yim, Chang-Yeol
    Sohn, Myung-Hee
    CANCER RESEARCH, 2012, 72
  • [6] OPHTHALMOLOGICAL FINDINGS IN GRAFT-VERSUS-HOST DISEASE (GVHD)
    KASMANN, B
    RUPRECHT, KW
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 1993, 202 (06) : 491 - 499
  • [7] CHRONIC GRAFT-VERSUS-HOST DISEASE (GVHD) IN MAN
    SULLIVAN, KM
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1986, : 213 - 213
  • [8] Female genital graft-versus-host disease (GVHD): a women's healthcare clinic initiative
    Van Damme, N.
    Lev-Sagie, A.
    Bogorochin, B.
    Levy, S.
    Or, R.
    Sapir, G.
    Radiano, R.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S463 - S463
  • [9] PUVA therapy for chronic graft-versus-host disease (GVHD)
    Vogelsang, GB
    Wolff, D
    Farmer, E
    Morison, W
    Corio, R
    Horn, T
    BLOOD, 1995, 86 (10) : 1580 - 1580
  • [10] Recent advances in graft-versus-host disease (GVHD) prevention
    Blazar, BR
    Korngold, R
    Vallera, DA
    IMMUNOLOGICAL REVIEWS, 1997, 157 : 79 - 109